Consolidated Statements of Comprehensive (Loss) Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (16,168)	$ 22,228
Other comprehensive loss:
Available for sale securities - net unrealized loss	(4)	(28)
Total other comprehensive loss	(4)	(28)
Comprehensive (loss) income	(16,172)	22,200
Comprehensive loss attributable to noncontrolling interests	(1)	(751)
Comprehensive (loss) income attributable to Caladrius Biosciences, Inc. common stockholders	$ (16,171)	$ 22,951